Evaluación del efecto in vitro de extractos intra y extracelulares de Lactobacillus contra la genotoxicidad y el estrés oxidativo causado por la acrilamida / Assessment of the in vitro effect of intra and extracellular extracts of Lactobacillus against genotoxicity and oxidative stress caused by acrylamide

Introducción: la acrilamida se forma mediante la reacción de Maillard, por lo que se encuentra en muchos productos alimenticios sometidos a procesos térmicos, generando genotoxicidad y daños al ADN. Los estudios han reportado que los lactobacilos tienen la capacidad de generar compuestos con actividad antioxidante, antigenotóxica y antimutagénica, y es por esto que el presente trabajo pretende evaluar el efecto de cepas de Lactobacillus y sus extractos intra y extracelulares contra la genotoxicidad y el estrés oxidativo causado por la acrilamida. Métodos: se empleó una cepa de Lactobacillus casei Shirota y una cepa de Lactobacillus reuteri NRRL B-14171. Ambas fueron cultivadas en caldo MRS y sometidas a tratamientos mecánicos y enzimáticos para obtener los extractos extra e intracelulares. Los linfocitos fueron cultivados en medio RPMI, la peroxidación lipídica se evaluó por TBARS y la capacidad antioxidante se midió en los extractos extra e intracelulares con la técnica ABTS, empleando además una cepa de Saccharomyces cerevisiae RC 212 como modelo. La reducción de la peroxidación lipídica en los linfocitos se midió por TBARS y la reducción de la genotoxicidad mediante la reducción de la formación de micronúcleos en los linfocitos. Resultados: ambas cepas evaluadas, así como sus extractos intra y extracelulares, mostraron capacidad de contrarrestar el estrés oxidativo y la genotoxicidad causada por la acrilamida. Conclusión: los resultados encontrados, sugieren que el empleo de extractos intra y extracelulares de ambas cepas podría ser una alternativa para reducir los efectos de genotoxicidad y estrés oxidativo causados por la acrilamida sin la necesidad de requerir una estructura viable.(AU)

Introduction: acrylamide is formed by the Maillard reaction and is found in many food products subjected to thermal processes, generating genotoxicity and DNA damage. Studies have reported that lactobacilli have the ability to generate compounds with antioxidant, antigenotoxic and antimutagenic activity, which is why the present work aims to evaluate the effect of Lactobacillus strains and their intra and extracellular extracts against genotoxicity and oxidative stress as caused by acrylamide.Methods: a strain of Lactobacillus casei Shirota and a strain of Lactobacillus reuteri NRRL B-14171 were used, both were cultured in MRS broth and subjected to mechanical and enzymatic treatments to obtain extra and intracellular extracts. Lymphocytes were cultured in RPMI medium. Lipid peroxidation was evaluated by TBARS and the antioxidant capacity was measured in the extra and intracellular extracts with the ABTS technique, also using a strain of Saccharomyces cerevisiae RC 212 as a model. The reduction of lipid peroxidation in lymphocytes was measured by TBARS and the reduction of genotoxicity by reducing the formation of micronuclei in lymphocytes.Results: both strains evaluated, as well as their intra and extracellular extracts, showed the ability to counteract oxidative stress and genotoxicity caused by acrylamide. Conclusion: the results found suggest that the use of intra and extracellular extracts of both strains could be an alternative to reduce the effects of genotoxicity and oxidative stress caused by acrylamide without the need for a viable structure.(AU)

[Assessment of the in vitro effect of intra and extracellular extracts of Lactobacillus against genotoxicity and oxidative stress caused by acrylamide]. / Evaluación del efecto in vitro de extractos intra y extracelulares de Lactobacillus contra la genotoxicidad y el estrés oxidativo causado por la acrilamida.

Introduction: Introduction: acrylamide is formed by the Maillard reaction and is found in many food products subjected to thermal processes, generating genotoxicity and DNA damage. Studies have reported that lactobacilli have the ability to generate compounds with antioxidant, antigenotoxic and antimutagenic activity, which is why the present work aims to evaluate the effect of Lactobacillus strains and their intra and extracellular extracts against genotoxicity and oxidative stress as caused by acrylamide. Methods: a strain of Lactobacillus casei Shirota and a strain of Lactobacillus reuteri NRRL B-14171 were used, both were cultured in MRS broth and subjected to mechanical and enzymatic treatments to obtain extra and intracellular extracts. Lymphocytes were cultured in RPMI medium. Lipid peroxidation was evaluated by TBARS and the antioxidant capacity was measured in the extra and intracellular extracts with the ABTS technique, also using a strain of Saccharomyces cerevisiae RC 212 as a model. The reduction of lipid peroxidation in lymphocytes was measured by TBARS and the reduction of genotoxicity by reducing the formation of micronuclei in lymphocytes. Results: both strains evaluated, as well as their intra and extracellular extracts, showed the ability to counteract oxidative stress and genotoxicity caused by acrylamide. Conclusion: the results found suggest that the use of intra and extracellular extracts of both strains could be an alternative to reduce the effects of genotoxicity and oxidative stress caused by acrylamide without the need for a viable structure.

Introducción: Introducción: la acrilamida se forma mediante la reacción de Maillard, por lo que se encuentra en muchos productos alimenticios sometidos a procesos térmicos, generando genotoxicidad y daños al ADN. Los estudios han reportado que los lactobacilos tienen la capacidad de generar compuestos con actividad antioxidante, antigenotóxica y antimutagénica, y es por esto que el presente trabajo pretende evaluar el efecto de cepas de Lactobacillus y sus extractos intra y extracelulares contra la genotoxicidad y el estrés oxidativo causado por la acrilamida. Métodos: se empleó una cepa de Lactobacillus casei Shirota y una cepa de Lactobacillus reuteri NRRL B-14171. Ambas fueron cultivadas en caldo MRS y sometidas a tratamientos mecánicos y enzimáticos para obtener los extractos extra e intracelulares. Los linfocitos fueron cultivados en medio RPMI, la peroxidación lipídica se evaluó por TBARS y la capacidad antioxidante se midió en los extractos extra e intracelulares con la técnica ABTS, empleando además una cepa de Saccharomyces cerevisiae RC 212 como modelo. La reducción de la peroxidación lipídica en los linfocitos se midió por TBARS y la reducción de la genotoxicidad mediante la reducción de la formación de micronúcleos en los linfocitos. Resultados: ambas cepas evaluadas, así como sus extractos intra y extracelulares, mostraron capacidad de contrarrestar el estrés oxidativo y la genotoxicidad causada por la acrilamida. Conclusión: los resultados encontrados, sugieren que el empleo de extractos intra y extracelulares de ambas cepas podría ser una alternativa para reducir los efectos de genotoxicidad y estrés oxidativo causados por la acrilamida sin la necesidad de requerir una estructura viable.

Nanohybrid of Thymol and 2D Simonkolleite Enhances Inhibition of Bacterial Growth, Biofilm Formation, and Free Radicals.

Due to the current concerns against opportunistic pathogens and the challenge of antimicrobial resistance worldwide, alternatives to control pathogen growth are required. In this sense, this work offers a new nanohybrid composed of zinc-layered hydroxide salt (Simonkolleite) and thymol for preventing bacterial growth. Materials were characterized with XRD diffraction, FTIR and UV-Vis spectra, SEM microscopy, and dynamic light scattering. It was confirmed that the Simonkolleite structure was obtained, and thymol was adsorbed on the hydroxide in a web-like manner, with a concentration of 0.863 mg thymol/mg of ZnLHS. Absorption kinetics was described with non-linear models, and a pseudo-second-order equation was the best fit. The antibacterial test was conducted against Escherichia coli O157:H7 and Staphylococcus aureus strains, producing inhibition halos of 21 and 24 mm, respectively, with a 10 mg/mL solution of thymol-ZnLHS. Moreover, biofilm formation of Pseudomonas aeruginosa inhibition was tested, with over 90% inhibition. Nanohybrids exhibited antioxidant activity with ABTS and DPPH evaluations, confirming the presence of the biomolecule in the inorganic matrix. These results can be used to develop a thymol protection vehicle for applications in food, pharmaceutics, odontology, or biomedical industries.

In-vivo assessment of the protection of Beta-glucans of Pleurotus ostreatus against oxidative stress caused by acrylamide intake (part II) / Evaluación in vivo de la proteccion de los beta-glucanos de Pleurotus ostreatus contra el estrés oxidativo causado por la ingesta de acrilamida (parte II)

INTRODUCTION: in April 2002, the National Food Authority of Sweden published a study in which the presence of a carcinogen was reported for the first time in experimental animals, and was identified as acrylamide. Various studies have shown that the β-glucans of Pleurotus ostreatus have diverse biological properties including antioxidant and anticancer activities. METHODS: β-glucans were obtained by alkaline-acid hydrolysis from Pleurotus ostreatus, and their content was characterized by liquid chromatography. To evaluate the effect of β-glucans on the expression of glutathione, Balb/c mice were used, and 4 test groups were established. All groups were fed as usual, groups treated with acrylamide were administered the compound intragastrically at a concentration of 50 μg/mL, and β-glucan treatment was given at a concentration of 50 μg/mL. RESULTS: no mortality was observed after exposure to the tested dose of acrylamide; only signs of peripheral neuropathy such as hyperactivity and tremors were observed after five days of experimentation, and were maintained over 30 days after the experiment. On the other hand, an increase in lipid peroxidation levels was observed in the livers of the acrylamide-treated mice, which were lower in the mice treated with β-glucans. CONCLUSIONS: results show that β-glucans may act as antioxidant agents able to protect the liver against oxidative stress as caused by the intake of acrylamide

INTRODUCCIÓN: en abril de 2002, la Autoridad Nacional de Alimentos de Suecia publicó un estudio en el que se informó por primera vez de la presencia de un carcinógeno en animales experimentales, identificado como acrilamida. Diversos estudios han demostrado que los β-glucanos de Pleurotus ostreatus tienen diversas propiedades biológicas, tales como actividades antioxidantes y anticancerígenas. MÉTODOS: los β-glucanos se obtuvieron por hidrólisis ácido-alcalina de Pleurotus ostreatus y su contenido se caracterizó por cromatografía líquida. Para evaluar el efecto de los β-glucanos sobre la expresión de glutatión, se usaron ratones Balb/c y se establecieron 4 grupos de prueba; todos los grupos se alimentaron normalmente, en los grupos tratados con acrilamida esta se administró intragástricamente a una concentración de 50 μg/mL, y el tratamiento con β-glucanos se dio a una concentración de 50 μg/mL. RESULTADOS: no se observó mortalidad después de la exposición a la dosis probada de acrilamida; solo se observaron signos de neuropatía periférica, como hiperactividad y temblores, después de cinco días de experimentación, que se mantuvieron dentro de los 30 días posteriores al experimento. Por otro lado, se observó un aumento de los niveles de peroxidación lipídica en los hígados de los ratones tratados con acrilamida, que fueron más bajos en los ratones tratados con β-glucanos. CONCLUSIONES: los resultados muestran que los β-glucanos podrían actuar como agentes antioxidantes y proteger el hígado contra el estrés oxidativo causado por la ingesta de acrilamida

In-vivo assessment of the protection of ß-glucans of Pleurotus ostreatus against oxidative stress caused by acrylamide intake (part II).

INTRODUCTION: Introduction: in April 2002, the National Food Authority of Sweden published a study in which the presence of a carcinogen was reported for the first time in experimental animals, and was identified as acrylamide. Various studies have shown that the ß-glucans of Pleurotus ostreatus have diverse biological properties including antioxidant and anticancer activities. Methods: ß-glucans were obtained by alkaline-acid hydrolysis from Pleurotus ostreatus, and their content was characterized by liquid chromatography. To evaluate the effect of ß-glucans on the expression of glutathione, Balb/c mice were used, and 4 test groups were established. All groups were fed as usual, groups treated with acrylamide were administered the compound intragastrically at a concentration of 50 g/mL, and ß-glucan treatment was given at a concentration of 50 g/mL. Results: no mortality was observed after exposure to the tested dose of acrylamide; only signs of peripheral neuropathy such as hyperactivity and tremors were observed after five days of experimentation, and were maintained over 30 days after the experiment. On the other hand, an increase in lipid peroxidation levels was observed in the livers of the acrylamide-treated mice, which were lower in the mice treated with ß-glucans. Conclusions: results show that ß-glucans may act as antioxidant agents able to protect the liver against oxidative stress as caused by the intake of acrylamide.

INTRODUCCIÓN: Introducción: en abril de 2002, la Autoridad Nacional de Alimentos de Suecia publicó un estudio en el que se informó por primera vez de la presencia de un carcinógeno en animales experimentales, identificado como acrilamida. Diversos estudios han demostrado que los ß-glucanos de Pleurotus ostreatus tienen diversas propiedades biológicas, tales como actividades antioxidantes y anticancerígenas. Métodos: los ß-glucanos se obtuvieron por hidrólisis ácido-alcalina de Pleurotus ostreatus y su contenido se caracterizó por cromatografía líquida. Para evaluar el efecto de los ß-glucanos sobre la expresión de glutatión, se usaron ratones Balb/c y se establecieron 4 grupos de prueba; todos los grupos se alimentaron normalmente, en los grupos tratados con acrilamida esta se administró intragástricamente a una concentración de 50 µg/mL, y el tratamiento con ß-glucanos se dio a una concentración de 50 µg/mL. Resultados: no se observó mortalidad después de la exposición a la dosis probada de acrilamida; solo se observaron signos de neuropatía periférica, como hiperactividad y temblores, después de cinco días de experimentación, que se mantuvieron dentro de los 30 días posteriores al experimento. Por otro lado, se observó un aumento de los niveles de peroxidación lipídica en los hígados de los ratones tratados con acrilamida, que fueron más bajos en los ratones tratados con ß-glucanos. Conclusiones: los resultados muestran que los ß-glucanos podrían actuar como agentes antioxidantes y proteger el hígado contra el estrés oxidativo causado por la ingesta de acrilamida.

In vivo assessment of the protection conferred by beta-glucans from Pleurotus ostreatus against the harmful effects of acrylamide intake (Part I) / Evaluación in vivo de la protección que confieren los beta-glucanos de Pleurotus ostreatus frente a los efectos nocivos de la ingestión de acrilamida (Parte I)

INTRODUCTION: acrylamide is formed in food through Maillard's reaction during thermal processing, and has been shown to be neurotoxic in humans, and a possible carcinogen. Studies have shown that β-glucans from Pleurotus ostreatus have diverse biological properties such as antioxidant and anticancer activities. OBJECTIVE: the aim of this work was to evaluate the protective effect of β-glucans from Pleurotus ostreatus against the harmful effects of acrylamide consumption in mice. METHODS: β-glucans were obtained by alkaline-acid hydrolysis of Pleurotus ostreatus, and the content was characterized by liquid chromatography. To evaluate the effect of β-glucans on the expression of glutathione, Balb/c mice were used, and 4 test groups were established. All groups were fed normally, and the groups treated with acrylamide were administered the compound intragastrically at a concentration of 50 μg/mL; β-glucans were administered at a concentration of 50 μg/mL. RESULTS: mice exposed to acrylamide showed a marked variation in the activity of glutathione enzymes in the liver. Significant differences (p < 0.05) were only found in the expression of glutathione transferase, which was increased almost 3 times in the group treated with β-glucans as compared with the control group, and 1.5 times as compared with the group treated with acrylamide. CONCLUSIONS: the results show that β-glucans could act by increasing the activity of enzymes involved in xenobiotic detoxification, thus protecting the biological system against the harmful effects caused by acrylamide intake

INTRODUCCIÓN: la acrilamida se forma en los alimentos a través de la reacción de Maillard durante el proceso térmico, y ha demostrado ser neurotóxica en humanos y un posible carcinógeno. Algunos estudios han demostrado que los β-glucanos de Pleurotus ostreatus tienen diversas propiedades biológicas, como actividades antioxidantes y anticancerígenas. OBJETIVO: el objetivo de este trabajo fue evaluar el efecto protector de los β-glucanos de Pleurotus ostreatus contra los efectos nocivos por consumo de acrilamida en ratones (prueba in vivo). MÉTODOS: los β-glucanos se obtuvieron por hidrólisis ácido-alcalina de Pleurotus ostreatus y su contenido se caracterizó por cromatografía líquida. La oxidación de los lípidos se evaluó mediante el método de TBARS, y para evaluar el efecto de los β-glucanos en la expresión de glutatión se usaron ratones Balb/c, y se establecieron 4 grupos de prueba. Todos los grupos fueron alimentados normalmente; a lo grupos tratados con acrilamida, esta se les administró intragástricamente en una concentración de 50 μg/ml, y los β-glucanos en una concentración de 50 μg/ml. RESULTADOS: en el presente trabajo, los ratones expuestos a acrilamida mostraron una marcada variación en la actividad de las enzimas de glutatión determinadas en el hígado. Solo se encontraron diferencias significativas (p < 0,05) en la expresión de glutatión-transferasa, que aumentó casi 3 veces en el grupo tratado con β-glucano en comparación con el grupo de control, y 1,5 veces con respecto al grupo tratado con acrilamida. CONCLUSIONES: los resultados muestran que los β-glucanos podrían actuar como agentes antioxidantes que protegen el hígado contra el estrés oxidativo causado por la ingesta de acrilamida

In vivo assessment of the protection conferred by ß-glucans from Pleurotus ostreatus against the harmful effects of acrylamide intake (Part I).

INTRODUCTION: Introduction: acrylamide is formed in food through Maillard's reaction during thermal processing, and has been shown to be neurotoxic in humans, and a possible carcinogen. Studies have shown that ß-glucans from Pleurotus ostreatus have diverse biological properties such as antioxidant and anticancer activities. Objective: the aim of this work was to evaluate the protective effect of ß-glucans from Pleurotus ostreatus against the harmful effects of acrylamide consumption in mice. Methods: ß-glucans were obtained by alkaline-acid hydrolysis of Pleurotus ostreatus, and the content was characterized by liquid chromatography. To evaluate the effect of ß-glucans on the expression of glutathione, Balb/c mice were used, and 4 test groups were established. All groups were fed normally, and the groups treated with acrylamide were administered the compound intragastrically at a concentration of 50 g/mL; ß-glucans were administered at a concentration of 50 g/mL. Results: mice exposed to acrylamide showed a marked variation in the activity of glutathione enzymes in the liver. Significant differences (p < 0.05) were only found in the expression of glutathione transferase, which was increased almost 3 times in the group treated with ß-glucans as compared with the control group, and 1.5 times as compared with the group treated with acrylamide. Conclusions: the results show that ß-glucans could act by increasing the activity of enzymes involved in xenobiotic detoxification, thus protecting the biological system against the harmful effects caused by acrylamide intake.

INTRODUCCIÓN: Introducción: la acrilamida se forma en los alimentos a través de la reacción de Maillard durante el proceso térmico, y ha demostrado ser neurotóxica en humanos y un posible carcinógeno. Algunos estudios han demostrado que los ß-glucanos de Pleurotus ostreatus tienen diversas propiedades biológicas, como actividades antioxidantes y anticancerígenas. Objetivo: el objetivo de este trabajo fue evaluar el efecto protector de los ß-glucanos de Pleurotus ostreatus contra los efectos nocivos por consumo de acrilamida en ratones (prueba in vivo). Métodos: los ß-glucanos se obtuvieron por hidrólisis ácido-alcalina de Pleurotus ostreatus y su contenido se caracterizó por cromatografía líquida. La oxidación de los lípidos se evaluó mediante el método de TBARS, y para evaluar el efecto de los ß-glucanos en la expresión de glutatión se usaron ratones Balb/c, y se establecieron 4 grupos de prueba. Todos los grupos fueron alimentados normalmente; a lo grupos tratados con acrilamida, esta se les administró intragástricamente en una concentración de 50 µg/ml, y los ß-glucanos en una concentración de 50 µg/ml. Resultados: en el presente trabajo, los ratones expuestos a acrilamida mostraron una marcada variación en la actividad de las enzimas de glutatión determinadas en el hígado. Solo se encontraron diferencias significativas (p < 0,05) en la expresión de glutatión-transferasa, que aumentó casi 3 veces en el grupo tratado con ß-glucano en comparación con el grupo de control, y 1,5 veces con respecto al grupo tratado con acrilamida. Conclusiones: los resultados muestran que los ß-glucanos podrían actuar como agentes antioxidantes que protegen el hígado contra el estrés oxidativo causado por la ingesta de acrilamida.

Optimization of the Synthesis of Structured Phosphatidylcholine with Medium Chain Fatty Acid.

Structured phosphatidylcholine was successfully produced by acidolysis between phosphatidylcholine and free medium chain fatty acid, using phospholipase A1 immobilized on Duolite A568. Response surface methodology was applied to optimize the reaction system using three process parameters: molar ratio of substrates (phosphatidylcholine to free medium chain fatty acid), enzyme loading, and reaction temperature. All parameters evaluated showed linear and quadratic significant effects on the production of modified phosphatidylcholine; molar ratio of substrates contributed positively, but temperature influenced negatively. Increased enzyme loading also led to increased production of modified phosphatidylcholine but only during the first 9 hours of the acidolysis reaction. Optimal conditions obtained from the model were a ratio of phosphatidylcholine to free medium chain fatty acid of 1:15, an enzyme loading of 12%, and a temperature of 45°C. Under these conditions a production of modified phosphatidylcholine of 52.98 % were obtained after 24 h of reaction. The prediction was confirmed from the verification experiments; the production of modified phosphatidylcholine was 53.02%, the total yield of phosphatidylcholine 64.28% and the molar incorporation of medium chain fatty acid was 42.31%. The acidolysis reaction was scaled-up in a batch reactor with a similar production of modified phosphatidylcholine, total yield of phosphatidylcholine and molar incorporation of medium chain fatty acid. Purification by column chromatography of the structured phosphatidylcholine yielded 62.53% of phosphatidylcholine enriched with 42.52% of medium chain fatty acid.

Enhanced Bioavailability of Curcumin Nanoemulsions Stabilized with Phosphatidylcholine Modified with Medium Chain Fatty Acids.

BACKGROUND: Curcumin is a natural, oil-soluble polyphenolic compound with potent anticancer, anti-inflammatory, and antioxidant activities. In its free form, it is very poorly absorbed in the gut due to its very low solubility. The use of nanoemulsions as carrier is a feasible way for improving curcumin bioavailability. To this end, the choice of emulsifying agent for stabilizing the nanoemulsions is of the upmost importance for achieving a desired functionality. METHODS: Phosphatidylcholine (PC) and phosphatidycholine enriched (PCE) with medium chain fatty acids (42.5 mol %) in combination with glycerol as co-surfactant, were used for preparing oil-in water nanoemulsions coded as NEPC and NEPCE, respectively. RESULTS: NEPCE displayed significantly smaller mean droplet size (30 nm), equal entrapment efficiency (100%), better droplet stability and suffered lower encapsulation efficiency loss (3%) during storage time (120 days, 4ºC) than NEPC. Bioavailability, measured in terms of area under the curve of curcumin concentration versus time, and maximum curcumin plasma concentration, was in general terms significantly higher for NEPCE than for NEPC, and for curcumin coarse aqueous suspension (CCS). Also, NEPCE produced significantly higher curcumin concentrations in liver and lung than NEPC and CCS. CONCLUSION: These data support the role of phosphatidylcholine enriched with medium chain fatty acids to increase the bioavailability of nanoemulsions for therapeutic applications.

Phosphatidylcholine enrichment with medium chain fatty acids by immobilized phospholipase A(1) -catalyzed acidolysis.

Phospholipids are a biologically and industrially important class of compounds whose physical properties can be improved for diverse applications by substitution of medium-chain fatty acids for their native fatty acid chains. In this study, phosphatidylcholine (PC) was enriched with medium-chain fatty acids (MCFAs) by acidolysis with phospholipase A(1) (PLA(1) ) immobilized on Duolite A568. Response surface methodology was employed to evaluate the effects of the molar ratio of substrates (PC to free MCFAs), enzyme loading, and reaction temperature on the incorporation of free MCFAs into PC and on PC recovery. Enzyme loading and molar ratio of substrates contributed positively, but temperature negatively, to the incorporation of free MCFAs into PC. Increases in enzyme loading and the molar ratio of PC to free MCFAs led to increased incorporation of the latter into the former, but increased temperature had the opposite effect. By contrast, an increase in enzyme loading led to decreased PC recovery. Increased temperature had also a negative effect on PC recovery. Optimal conditions for maximum incorporation and PC recovery were molar ratio of PC to free MCFAs of 1:16, enzyme loading of 16%, and 50°C. Under these conditions, the incorporation of free MCFAs was 41% and the PC recovery was 53%.